Cargando…
Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes
BACKGROUND: In addition to improving survival outcomes, new oncology treatments should lead to amelioration of patients’ quality of life (QoL). Herein, we examined whether QoL results correlated with PFS and OS outcomes in phase III randomized controlled trials (RCTs) investigating new systemic trea...
Autores principales: | Servetto, Alberto, Di Maio, Massimo, Salomone, Fabio, Napolitano, Fabiana, Paratore, Chiara, Di Costanzo, Fabrizio, Viscardi, Giuseppe, Santaniello, Antonio, Formisano, Luigi, Bianco, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318754/ https://www.ncbi.nlm.nih.gov/pubmed/37400832 http://dx.doi.org/10.1186/s12916-023-02953-0 |
Ejemplares similares
-
Tumour Microenvironment and Immune Evasion in EGFR Addicted NSCLC: Hurdles and Possibilities
por: Santaniello, Antonio, et al.
Publicado: (2019) -
A Narrative Approach to Describe QoL in Children With Chronic ITP
por: Giordano, Paola, et al.
Publicado: (2019) -
QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC
por: Yang, Yun-Peng, et al.
Publicado: (2015) -
Corrigendum: A Narrative Approach to Describe QoL in Children With Chronic ITP
por: Giordano, Paola, et al.
Publicado: (2019) -
Validation of the Dutch version of the Swallowing Quality-of-Life Questionnaire (DSWAL-QoL) and the adjusted DSWAL-QoL (aDSWAL-QoL) using item analysis with the Rasch model: a pilot study
por: Simpelaere, Ingeborg S., et al.
Publicado: (2017)